Dr. Mark Andolina, MD

NPI: 1346451051
Total Payments
$469,821
2024 Payments
$118,632
Companies
36
Transactions
464
Medicare Patients
2,516
Medicare Billing
$421,233

Payment Breakdown by Category

Other$415,190 (88.4%)
Travel$40,752 (8.7%)
Food & Beverage$11,045 (2.4%)
Consulting$2,756 (0.6%)
Education$77.27 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $415,190 140 88.4%
Travel and Lodging $40,752 126 8.7%
Food and Beverage $11,045 189 2.4%
Consulting Fee $2,756 4 0.6%
Education $77.27 5 0.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $252,758 204 $0 (2024)
Regeneron Healthcare Solutions, Inc. $104,259 87 $0 (2024)
Merck Sharp & Dohme LLC $100,960 102 $0 (2024)
Janssen Biotech, Inc. $10,702 15 $0 (2024)
Galvanize Therapeutics, Inc $116.19 1 $0 (2023)
Incyte Corporation $106.55 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $89.23 4 $0 (2024)
Astellas Pharma US Inc $72.16 4 $0 (2020)
Genentech USA, Inc. $65.44 5 $0 (2023)
PFIZER INC. $62.53 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $118,632 116 Regeneron Healthcare Solutions, Inc. ($79,987)
2023 $68,370 72 Merck Sharp & Dohme LLC ($27,844)
2022 $62,158 46 Janssen Pharmaceuticals, Inc ($61,916)
2021 $30,164 34 Janssen Pharmaceuticals, Inc ($29,918)
2020 $15,269 17 Merck Sharp & Dohme Corporation ($7,927)
2019 $44,137 42 Janssen Pharmaceuticals, Inc ($24,418)
2018 $56,305 50 Janssen Pharmaceuticals, Inc ($31,884)
2017 $74,786 87 Janssen Pharmaceuticals, Inc ($60,413)

All Payment Transactions

464 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/17/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,770.00 General
Category: Oncology
12/17/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $8.79 General
Category: Oncology
12/11/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $121.59 General
Category: Oncology
12/10/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,660.00 General
Category: ONCOLOGY
11/21/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,928.00 General
Category: ONCOLOGY
11/15/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $64.65 General
Category: ONCOLOGY
11/13/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $21.24 General
Category: Oncology
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $261.97 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $261.97 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $188.27 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $188.27 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $60.64 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $49.08 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $44.00 General
Category: ONCOLOGY
11/12/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $28.96 General
Category: ONCOLOGY
11/11/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $185.10 General
Category: ONCOLOGY
11/11/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $80.06 General
Category: ONCOLOGY
11/11/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $70.71 General
Category: ONCOLOGY
11/11/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $36.77 General
Category: ONCOLOGY
11/11/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $10.51 General
Category: ONCOLOGY
11/08/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $196.25 General
Category: ONCOLOGY
11/07/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,124.00 General
Category: ONCOLOGY
11/07/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Travel and Lodging In-kind items and services $217.31 General
Category: ONCOLOGY
11/07/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $137.18 General
Category: ONCOLOGY
11/07/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $38.73 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 602 979 $266,032 $82,331
2022 10 598 1,140 $289,224 $111,360
2021 10 672 1,325 $327,933 $130,449
2020 11 644 1,204 $279,407 $97,093
Total Patients
2,516
Total Services
4,648
Medicare Billing
$421,233
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 147 195 $30,810 $8,896 28.9%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 56 57 $25,878 $8,130 31.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 48 48 $17,328 $4,920 28.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 54 73 $11,753 $4,179 35.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 21 21 $9,471 $3,270 34.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 25 36 $8,352 $2,961 35.5%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 25 25 $7,625 $2,711 35.6%
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a Office 2020 49 187 $29,920 $29,424 98.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 155 427 $100,345 $24,901 24.8%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 67 155 $49,135 $13,446 27.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 146 183 $28,914 $6,559 22.7%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 45 45 $20,430 $6,033 29.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 59 80 $12,880 $4,658 36.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 38 38 $11,590 $4,121 35.6%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 40 40 $14,440 $3,774 26.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 15 15 $6,765 $2,379 35.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 13 14 $3,248 $1,179 36.3%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 17 20 $1,740 $617.01 35.5%

About Dr. Mark Andolina, MD

Dr. Mark Andolina, MD is a Internal Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346451051.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Andolina, MD has received a total of $469,821 in payments from pharmaceutical and medical device companies, with $118,632 received in 2024. These payments were reported across 464 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($415,190).

As a Medicare-enrolled provider, Andolina has provided services to 2,516 Medicare beneficiaries, totaling 4,648 services with total Medicare billing of $421,233. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hematology & Oncology
  • Location Cincinnati, OH
  • Active Since 05/24/2007
  • Last Updated 10/28/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1346451051

Products in Payments

  • XARELTO (Drug) $252,758
  • LIBTAYO (Biological) $104,259
  • KEYTRUDA (Biological) $96,667
  • RYBREVANT (Drug) $10,685
  • ALIYA SYSTEM (Device) $116.19
  • MONJUVI (Drug) $106.55
  • IMBRUVICA (Drug) $53.95
  • XTANDI (Drug) $46.06
  • Xtandi (Drug) $40.10
  • PADCEV (Biological) $36.14
  • NERLYNX (Drug) $26.27
  • Phesgo (Biological) $24.94
  • SAMSCA (Drug) $24.50
  • ENHERTU (Biological) $24.33
  • Lenvima (Drug) $24.27
  • KISQALI (Drug) $22.68
  • BENDEKA (Drug) $22.64
  • CALQUENCE (Drug) $21.24
  • Fabhalta (Drug) $20.16
  • KIMMTRAK (Drug) $20.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Cincinnati